DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam
· Delayed Price · Currency is VND 100,000
+300 (0.30%)
At close: Apr 29, 2026
DHG Pharmaceutical JSC Revenue
DHG Pharmaceutical JSC had revenue of 1.20T VND in the quarter ending March 31, 2026, with 0.30% growth. This brings the company's revenue in the last twelve months to 5.27T, up 9.33% year-over-year. In the year 2025, DHG Pharmaceutical JSC had annual revenue of 5.27T with 7.82% growth.
Revenue (ttm)
5,270.52B
Revenue Growth
+9.33%
P/S Ratio
2.47
Revenue / Employee
1.88B
Employees
2,819
Market Cap
13.04T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5,266.96B | 382.10B | 7.82% |
| Dec 31, 2024 | 4,884.87B | -130.53B | -2.60% |
| Dec 31, 2023 | 5,015.40B | 339.38B | 7.26% |
| Dec 31, 2022 | 4,676.02B | 672.85B | 16.81% |
| Dec 31, 2021 | 4,003.17B | 247.55B | 6.59% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Imexpharm | 2,393.23B |
| Ha Tay Pharmaceutical JSC | 2,402.04B |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1,865.38B |
| Traphaco JSC | 2,657.21B |
| Cuu Long Pharmaceutical JSC | 1,321.59B |
| Domesco Medical Import - Export Joint-Stock | 2,117.78B |
| OPC Pharmaceutical JSC | 1,122.99B |
| Central Pharmaceutical Joint Stock Company No3 | 481.09B |